Ligand validation:9C8A

FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE

FDA is a Ligand Of Interest in 9C8A designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9C8A_FDA_B_601	98%	7%	0.054	0.973	2.86	1.92	23	18	3	0	100%	0.59
9C8A_FDA_A_601	97%	7%	0.056	0.972	2.83	1.97	19	14	3	0	100%	0.63
9C8B_FDA_A_601	98%	8%	0.054	0.974	2.74	1.88	21	13	2	0	100%	0.63
3TSH_FDA_A_601	100%	38%	0.04	0.992	1.03	1.38	3	6	3	0	100%	1
3ATR_FDA_A_501	100%	23%	0.039	0.986	1.34	1.81	5	16	1	0	100%	1
7AA2_FDA_A_701	100%	60%	0.043	0.986	0.69	0.83	-	1	3	0	100%	1
4MOO_FDA_A_801	100%	24%	0.041	0.982	1.42	1.67	7	14	2	0	100%	1
6ZE6_FDA_A_701	100%	60%	0.044	0.984	0.72	0.8	-	1	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.